DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 76,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Follow-Up Questions
DaVita Inc (DVA)의 PER은 얼마입니까?
DaVita Inc의 PER은 9.9143입니다
DaVita Inc의 CEO는 누구입니까?
Mr. Javier Rodriguez은 2000부터 회사에 합류한 DaVita Inc의 Chief Executive Officer입니다.
DVA 주식의 가격 성능은 어떻습니까?
DVA의 현재 가격은 $130.23이며, 전 거래일에 decreased 0% 하였습니다.
DaVita Inc의 주요 사업 주제나 업종은 무엇입니까?
DaVita Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
DaVita Inc의 시가총액은 얼마입니까?
DaVita Inc의 현재 시가총액은 $9.3B입니다
DaVita Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 10명의 분석가가 DaVita Inc에 대한 분석 평가를 실시했으며, 이는 0명의 강력한 매수, 1명의 매수, 10명의 보유, 5명의 매도, 그리고 0명의 강력한 매도를 포함합니다